Dashboard
1
Strong ability to service debt as the company has a low Debt to EBITDA ratio of 0.91 times
2
Poor long term growth as Operating profit has grown by an annual rate -2.08% of over the last 5 years
3
Flat results in Mar 25
4
With ROCE of 10.28%, it has a very attractive valuation with a 0.83 Enterprise value to Capital Employed
5
Market Beating Performance
Stock DNA
Specialty Chemicals
JPY 250,939 Million (Small Cap)
10.00
NA
0.03%
0.10
8.39%
0.96
Revenue and Profits:
Net Sales:
89,686 Million
(Quarterly Results - Mar 2025)
Net Profit:
6,445 Million
Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
11.46%
0%
11.46%
6 Months
39.66%
0%
39.66%
1 Year
53.27%
0%
53.27%
2 Years
81.75%
0%
81.75%
3 Years
118.91%
0%
118.91%
4 Years
121.05%
0%
121.05%
5 Years
72.7%
0%
72.7%
Tokuyama Corp. for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
1.65%
EBIT Growth (5y)
-2.08%
EBIT to Interest (avg)
19.70
Debt to EBITDA (avg)
0.91
Net Debt to Equity (avg)
0.11
Sales to Capital Employed (avg)
0.95
Tax Ratio
25.67%
Dividend Payout Ratio
30.76%
Pledged Shares
0
Institutional Holding
0.02%
ROCE (avg)
9.57%
ROE (avg)
8.94%
Valuation key factors
Factor
Value
P/E Ratio
10
Industry P/E
Price to Book Value
0.81
EV to EBIT
8.03
EV to EBITDA
4.85
EV to Capital Employed
0.83
EV to Sales
0.70
PEG Ratio
0.37
Dividend Yield
0.03%
ROCE (Latest)
10.28%
ROE (Latest)
8.46%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Bullish
Bullish
RSI
Bearish
Bearish
Bollinger Bands
Mildly Bullish
Mildly Bullish
Moving Averages
Bullish (Daily)
KST
Mildly Bearish
Bullish
Dow Theory
Bullish
Bullish
OBV
Mildly Bearish
No Trend
Shareholding Snapshot : Sep 2011
Shareholding Compare (%holding) 
Majority shareholders
Foreign Institutions
Domestic Funds
Held in 0 Schemes (0%)
Foreign Institutions
Held by 1 Foreign Institutions (0.02%)
Strategic Entities with highest holding
Highest Public shareholder
Quarterly Results Snapshot (Consolidated) - Mar'25 - YoY
Mar'25
Mar'24
Change(%)
Net Sales
89,686.00
91,735.00
-2.23%
Operating Profit (PBDIT) excl Other Income
13,957.00
13,401.00
4.15%
Interest
246.00
238.00
3.36%
Exceptional Items
1,973.00
-271.00
828.04%
Consolidate Net Profit
6,445.00
5,633.00
14.42%
Operating Profit Margin (Excl OI)
99.20%
94.80%
0.44%
USD in Million.
Net Sales
YoY Growth in quarter ended Mar 2025 is -2.23% vs -1.13% in Mar 2024
Consolidated Net Profit
YoY Growth in quarter ended Mar 2025 is 14.42% vs 532.21% in Mar 2024
Annual Results Snapshot (Consolidated) - Mar'25
Mar'25
Mar'24
Change(%)
Net Sales
343,073.00
341,990.00
0.32%
Operating Profit (PBDIT) excl Other Income
49,657.00
43,409.00
14.39%
Interest
912.00
1,333.00
-31.58%
Exceptional Items
1,006.00
-275.00
465.82%
Consolidate Net Profit
23,278.00
17,411.00
33.70%
Operating Profit Margin (Excl OI)
87.40%
75.00%
1.24%
USD in Million.
Net Sales
YoY Growth in year ended Mar 2025 is 0.32% vs -2.79% in Mar 2024
Consolidated Net Profit
YoY Growth in year ended Mar 2025 is 33.70% vs 85.98% in Mar 2024
About Tokuyama Corp. 
Tokuyama Corp.
Specialty Chemicals
No Details Available.
Company Coordinates 
No Company Details Available






